Keck Annual USC Update in GI and Liver Diseases: Controversies and Guidelines in 2025

Keck Annual USC Update in GI and Liver Diseases Controversies and Guidelines in 2025

1. Identify advances in third-space endoscopy and complicated biliary cases.
2. Explain the role of supportive techniques in the evaluation of esophageal disorders and how best to evaluate belching, bloating, distention, and other common GI symptoms.
3. Review updates in the medical management of IBD and the management of dysplasia.
4. Outline the newest screening and surveillance approaches for colorectal and pancreatic cancer.
5. Describe the evaluation process for both living liver donors and recipients, encompassing medical, surgical, and patient perspectives, to ensure optimal outcomes and minimize risks associated with living donor liver transplants.
6. Recognize the pathophysiology and clinical implications of acute kidney injury in cirrhosis, including its impact on patient prognosis and management strategies, to improve early detection and treatment approaches in clinical practice.
7. Review the latest advancements in treatments for hepatocellular carcinoma (HCC), including surgical, locoregional, and systemic therapies.
8. Describe methods to optimize the care of the ambulatory patient with cirrhosis and prevent decompensation.
9. Discover insights into recent advances in managing metabolic dysfunction associated with steatohepatitis (MASH), including pharmacological and lifestyle interventions, to address the growing burden of MASH-related liver disease and improve patient outcomes.
10. Examine the latest developments in hepatitis B treatment, including antiviral therapies.

Annual USC Update in GI and Liver Diseases 2025

Controversies and Guidelines in 2025